Results 201 to 210 of about 160,265 (347)

Imaging efficacy and safety of low dose intraventricular tissue plasminogen activator in aneurysmal subarachnoid hemorrhage: case series. [PDF]

Acta Neurochir (Wien)
Liu C, Wroe WW, Zeineddine HA, Dawes B, Giordano M, McCabe A, Chen CJ, McBride DW, Gusdon AM, Choi HA, Blackburn SL.   +10 more
europepmc   +1 more source

A Pilot Investigation of Transforming Growth Factor‐β2 and Total Protein Concentrations in Aqueous Humor of Canine Glaucomatous Eyes With and Without Ahmed Glaucoma Valve Surgery

Veterinary Ophthalmology, EarlyView.
ABSTRACT Objective To investigate responses to surgical interventions in concentrations of transforming growth factor‐β2 (TGF‐β2) and total protein (TP) in the aqueous humor (AH) of primary angle‐closure glaucoma (PACG) eyes, with and without Ahmed glaucoma valve surgery in dogs.
Songhui Lee, Kangmoon Seo, Seonmi Kang
wiley   +1 more source

Tissue plasminogen activator modified thromboelastography identifies fibrinolysis resistance in dogs with immune-mediated hemolytic anemia. [PDF]

Front Vet Sci
Goggs R, Davis S, Brooks MB.
europepmc   +1 more source

Activation And “Inactivation” Of A Plasminogen Proactivator (Preurokinase) In Human Tissue Culture Media [PDF]

, 1981
G. Wijngaards, Maria B. Bernik
openalex   +1 more source

Environmental modulators of vascular physiology and inflammation

Experimental Physiology, EarlyView.
Abstract Environmental factors play a crucial role in modulating vascular inflammation, contributing significantly to the development of atherosclerosis and cardiovascular disease. This review synthesizes current evidence on how various environmental exposures influence vascular function and inflammation, with a focus on pollutants such as particulate ...
Anusha N. Seneviratne, Anne Majumdar, Kalpana Surendranath, Mark R. Miller   +3 more
wiley   +1 more source

Enhancing Thrombolysis Safety in Post-Acute Ischemic Stroke with Tissue Plasminogen Activator-Associated Microparticles. [PDF]

ACS Nano
Spanò R, Portioli C, Geroski T, Felici A, Palange AL, Gawne PJ, Mamberti S, Avancini G, Palomba R, Bonnard T, Moore TL, Del Sette M, Filipovic N, Vivien D, Decuzzi P.   +14 more
europepmc   +1 more source

PAF-acether-induced release of tissue-type plasminogen activator from vessel walls [PDF]

, 1985
J.J. Emeis, C Kluft
openalex   +1 more source

Cellular and molecular cross‐talk in atrial fibrillation: The role of non‐cardiomyocytes in creating an arrhythmogenic substrate

The Journal of Physiology, EarlyView.
Abstract figure legend Illustration of cellular and molecular cross‐talk in atrial fibrillation. Left: a schematic of cardiac tissue showing cardiomyocytes, fibroblasts, adipocytes, inflammatory cells and the coagulation system. Right: direct and indirect cross‐talk between different cell types, with the impact of direct cross‐talk on action potential (
Zhenyu Dong, Ruben Coronel, Joris R. de Groot   +2 more
wiley   +1 more source

Outcomes of Emergent Stenting with Antiplatelet Therapy in Patients with Large Vessel Occlusion Stroke with or without Intravenous Tissue Plasminogen Activator. [PDF]

J Neuroendovasc Ther
Teranishi K, Fujiwara S, Sunohara T, Koyanagi M, Goto M, Takeda J, Fukumitsu R, Fukui N, Takano Y, Nakajima K, Naramoto Y, Yamamoto Y, Nishii R, Kawade S, Takamatsu T, Tokuda M, Tomita H, Yoshimoto M, Ohara N, Sakai N, Ohta T.   +20 more
europepmc   +1 more source

Production of monoclonal antibodies to the high fibrin-affinity, tissue- type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization [PDF]

, 1985
Eduardo Anglés‐Cano, A Balaton, B Le Bonniec, E Genot, J Elion, Y Sultan   +5 more
openalex   +1 more source